ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
5 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
13K
|
6.1M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Jefferies Role
|
|
ashgood123
|
9 |
4.7K |
9 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
9
|
4.7K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
23 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
1.4K
|
781K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
13K
|
6.1M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
11 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
1.4K
|
781K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
4 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
1.4K
|
781K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
4 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
13K
|
6.1M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
ashgood123
|
131 |
62K |
19 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
131
|
62K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
ashgood123
|
131 |
62K |
10 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
131
|
62K
|
10
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
ashgood123
|
2.0K |
1.0M |
11 |
12/01/24 |
12/01/24 |
Charts
|
2.0K
|
1.0M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
50 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
1.4K
|
781K
|
50
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
13 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
1.4K
|
781K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
3 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
13K
|
6.1M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
ashgood123
|
108 |
66K |
6 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
108
|
66K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
4 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
1.4K
|
781K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
20 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
1.4K
|
781K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
7 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
13K
|
6.1M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
ashgood123
|
166 |
80K |
21 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
166
|
80K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
4 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
13K
|
6.1M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
ashgood123
|
40 |
20K |
20 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
40
|
20K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
ashgood123
|
166 |
80K |
1 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
80K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
ashgood123
|
166 |
80K |
2 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
80K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
ashgood123
|
166 |
80K |
7 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
80K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
ashgood123
|
166 |
80K |
10 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
80K
|
10
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
ashgood123
|
2.0K |
1.0M |
2 |
02/01/24 |
02/01/24 |
Charts
|
2.0K
|
1.0M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
24 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
1.4K
|
781K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Market Capitalisation is a Better Valuation Metric Than Share Price
|
|
ashgood123
|
100 |
64K |
13 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
100
|
64K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
82 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
82
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
54 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
54
|
|
ASX - By Stock
|
NEU |
Re:
Morgans target is $31 and others $26.43 & 27.31
|
|
ashgood123
|
25 |
13K |
12 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
25
|
13K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Bristol Myers to acquire Karuna for $14Billion
|
|
ashgood123
|
30 |
17K |
6 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
30
|
17K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
8 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
2 |
24/12/23 |
24/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
17 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Take Over Opportunity
|
|
ashgood123
|
48 |
25K |
18 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
48
|
25K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
4 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
2 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
25 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Happy Holidays
|
|
ashgood123
|
42 |
16K |
5 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
42
|
16K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
ashgood123
|
52 |
36K |
18 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
52
|
36K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
ashgood123
|
30 |
14K |
6 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
30
|
14K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
18 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
1.4K
|
781K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
14 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
1.4K
|
781K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
8 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
16 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
ashgood123
|
30 |
14K |
8 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
30
|
14K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
ashgood123
|
210 |
93K |
10 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
93K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
ashgood123
|
13K |
6.1M |
31 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
13K
|
6.1M
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
ashgood123
|
210 |
93K |
12 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
93K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
ashgood123
|
1.4K |
781K |
26 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
1.4K
|
781K
|
26
|
|